Janssen’s drug looking to gain bigger share in crowded myeloma market
Phase 1 trial will investigate safety and tolerability in non-small cell lung cancer.
A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Growing patients’ cells in the lab into structures that maintain the characteristics of the patient can help speed drug discovery and tailor treatments.
Reactions of healthcare professionals to Jeremy Hunt staying as Health Secretary.